L
LightDeck Diagnostics
Comprehensive diagnosis at the point of care
About LightDeck Diagnostics
LightDeck Diagnostics operates in the medical diagnostics market, providing advanced testing solutions through its innovative planar waveguide technology. The company serves healthcare providers, laboratories, and industries requiring rapid and accurate diagnostic results. LightDeck's core product is a portable analyzer that uses inexpensive, disposable test cartridges to deliver lab-quality results in minutes. This technology is particularly valuable in situations requiring quick decision-making, such as emergency rooms or remote locations. The business model revolves around the sale of these analyzers and recurring revenue from the disposable cartridges. LightDeck Diagnostics generates revenue through direct sales and partnerships with healthcare institutions and governmental bodies. The company has received several awards and certifications, including ISO 13485, which affirms its commitment to quality management. Recent funding rounds, such as the $11 million Series B, support the development of new tests, including a 5-minute COVID-19 test.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2009
- Headquarters
- Boulder, United States
- Employees
- 77
- Open positions
- None listed
- Dealroom signal
- 46.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Sep 2022 | $39M | $39M | HESKA | ↗ |
| GRANTOther financing | Jun 2022 | — | — | National Institute of Food and Agriculture | ↗ |
Growth signals
Latest recorded traffic for LightDeck Diagnostics is 790 monthly website visits, up 49.1% over the last three months. LightDeck Diagnostics's team grew 48.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
US National Science Foundation
National Institute of Food and Agriculture
Series A4 investors entered at this stage
HESKA
Boulder Ventures
Incubic Venture Fund
Entrada Ventures
Series B and later1 investor entered at this stage
Capital for Founders
Other known investors5 additional known investors
Arizona Tech Investors
HHS Administration for Strategic Preparedness and Response
Rockies Seed Fund
Small Business Innovation Research
US Biomedical Advanced Research and Development Authority
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about LightDeck Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LightDeck Diagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.